TickerFactsScreenerDevelopers

Imunon, Inc. (IMNN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $6.92M2010: $1.14M2011: $20.15M2012: $14.99M2013: $5.72M2014: $12.69M2015: $9.27M2016: $2.62M2017: $11.44M2018: $13.35M2019: $6.88M2020: $17.16M2021: $19.59M2022: $11.49M2023: $5.84M2024: $5.87M2025: $8.78M$8.78M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$8.78M+49.5%
2024$5.87M+0.6%
2023$5.84M-49.2%
2022$11.49M-41.3%
2021$19.59M+14.1%
2020$17.16M+149.7%
2019$6.88M-48.5%
2018$13.35M+16.7%
2017$11.44M+336.1%
2016$2.62M-71.7%
2015$9.27M-27.0%
2014$12.69M+121.9%
2013$5.72M-61.9%
2012$14.99M-25.6%
2011$20.15M+1668.9%
2010$1.14M-83.5%
2009$6.92M—